Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Bristol-Myers Squibb Co (NYSE:BMY)

55.06
BATS BZX Real-Time Price
As of 1:45pm ET
 -0.68 / -1.22%
Today’s Change
54.93
Today|||52-Week Range
77.12
-19.96%
Year-to-Date
Bristol-Myers Squibb Slides Into Value-Stock Territory
11:06am / TheStreet.com - Paid Partner Content
Bristol-Myers Squibb Stock Is Down, but That Means You Should Buy
Sep 22 / TheStreet.com - Paid Partner Content
Jim Cramer's Top Takeaways: Thor Industries, e.l.f. Beauty, Bristol-Myers Squibb
6:03am / TheStreet.com - Paid Partner Content
52-Week Company Lows
Sep 22 / GuruFocus News - Paid Partner Content
Bristol, Nektar Research Pact Aims to Boost Efficacy of Cancer Immunotherapy
Sep 27 / TheStreet.com - Paid Partner Content
Gilead to Stop GS-5745 Development for Ulcerative Colitis
Sep 22 / Zacks.com - Paid Partner Content
Dr. Lisa Bardacks Faustian Bargain
Sep 25 / Investing Channel - Paid Partner Content
Bristol-Myers Opdivo's Regulatory Application Validated in EU
Sep 21 / Zacks.com - Paid Partner Content
Pharma Stock Roundup: Allergan Acquisitions in Focus, J&J to Buy Abbott's AMO
Sep 23 / Zacks.com - Paid Partner Content
Opinions split on Witty regime at GSK
Sep 20 / FT.com - Paid Partner Content

Today’s Trading

Previous close55.74
Today’s open55.77
Day’s range54.93 - 55.77
Volume455,210
Average volume (3 months)9,759,250
Market cap$93.1B
Dividend yield2.76%
Data as of 1:45pm ET, 09/28/2016

Growth & Valuation

Earnings growth (last year)-22.50%
Earnings growth (this year)+30.14%
Earnings growth (next 5 years)+20.00%
Revenue growth (last year)+4.29%
P/E ratio32.2
Price/Sales6.97
Price/Book6.49

Competitors

 Today’s
change
Today’s
% change
AGNAllergan-2.11-0.88%
LLYEli Lilly and Co-0.32-0.40%
SNYSanofi+0.34+0.89%
NVONovo Nordisk-0.27-0.60%
Data as of 1:45pm ET, 09/28/2016

Financials

Next reporting dateOctober 27, 2016
EPS forecast (this quarter)$0.64
Annual revenue (last year)$16.6B
Annual profit (last year)$1.6B
Net profit margin9.45%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
Chief Executive Officer &
Director
Giovanni Caforio
Chief Financial Officer &
Executive Vice President
Charles A. Bancroft
Corporate headquarters
New York, New York

Forecasts

Search for Jobs